abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
36294: Adalimumab Anti-drug Antibody For Ibd Print View
Adalimumab ADA, IBD ELISA    AU 
Interpretation      
Comment      

PRIMARY
1 Serum Red Top 1 (0.5) mL   Room Temperature - 48 Hour(s)/Refrigerated - 7 Day(s)/Frozen - 14 Day(s)  
ALTERNATE

When treatment of inflammatory bowel disease with adalimumab fails, a physician may need to consider treatment options, such as adjusting dose or dosing intervals, switching to a different TNF blocker, or switching to a different drug agent, i.e. a non-TNF blocker. This assay specifically detects antibodies to adalimumab that may reduce serum levels of the drug, as well as its clinical efficacy.

Patient Preparation: No biotin supplements 48 hours prior to blood
draw. Fasting not required
Setup Schedule
Tuesday

Reported (Analytical Time)
2 days

CPT Code
83520

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
**This test is not available for New York patient testing**
Reject Criteria: Serum Separator Tube
Transport Temperature: Refrigerated
Specimen Stability:
Frozen (-20 degrees Celsius): 14 days
Frozen (-70 degrees Celsius): 60 days
Methodology: Enzyme Linked Immunosorbent Assay






1996 - 2018 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database